Iron complexes of hydroxypyridones useful for treating iron over

Details Iron complexes of hydroxypyridones useful for treating iron over Iron complexes of hydroxypyridones useful for treating iron over

1989-09-01

1992-04-14

Henderson, Christopher

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514184, A61K 31555

Patent

active

051048655

ABSTRACT:
Compounds in which two or more rings, being a 3-hydroxpypyrid-2-one, 3-hydroxypyrid-4-one or 1-hydroxpyrid-2-one, are linked are of value in the treatment of patients having a toxic concentration of a metal, particularly iron, in the body while the iron complexes of such compounds are of value in the treatment of iron deficiency anaemia.

REFERENCES:
patent: 2429096 (1947-10-01), Ladd et al.
patent: 2686786 (1954-08-01), Shaw et al.
patent: 2742476 (1956-04-01), Bernstein et al.
patent: 2748142 (1956-05-01), Clauson-Kass
patent: 3236733 (1966-02-01), Karsten
patent: 3269904 (1966-08-01), Bernstein
patent: 3281366 (1966-10-01), Judge
patent: 3419570 (1968-12-01), Brammer
patent: 3705943 (1972-12-01), Kaufman
patent: 3810752 (1974-05-01), Merril Wilcox
patent: 3847927 (1974-11-01), Dunbar
patent: 3864334 (1974-09-01), Pallos
patent: 3928616 (1975-12-01), Pallos
patent: 3963729 (1976-06-01), Gittos
patent: 3968118 (1976-07-01), Lohaus
patent: 4018907 (1977-04-01), Scarpellino
patent: 4018934 (1977-04-01), Parliment
patent: 4063927 (1977-12-01), Otten et al.
patent: 4143131 (1979-03-01), Lindenbaum
patent: 4181654 (1980-01-01), Weitl et al.
patent: 4225614 (1980-09-01), Hansson
patent: 4279936 (1981-07-01), Jones
patent: 4293542 (1981-10-01), Lang et al.
patent: 4309305 (1982-01-01), Weitl et al.
patent: 4396766 (1983-08-01), Farmer, Jr. et al.
patent: 4397867 (1983-08-01), Blake
patent: 4419365 (1983-12-01), McLachlan
patent: 4442305 (1984-04-01), Weitl et al.
patent: 4530963 (1985-07-01), DeVoe et al.
patent: 4543213 (1985-09-01), Weitl et al.
patent: 4575502 (1986-03-01), Hider
patent: 4585780 (1986-04-01), Hider et al.
patent: 4587240 (1986-05-01), Hider et al.
patent: 4698431 (1987-10-01), Raymond et al.
Itoh et al., "The Journal of Antibiotics", vol. XXXII, No. 11, pp. 1089-1095 (Nov. 1979). This document discloses 6-methyl-5-methoxy-1-hydroxypyrid-. . .
Barker et al., CA 92:179021g, and the Journal of Antibiotics, vol. 32, No. 11, 1979, pp. 1096-1103. These documents relate to the studies on the . . .
McInnes et al., Journal of the Chemical Society, Chemical Communications, 1974, No. 8, 281-282. This paper relates to two pigment compounds which . . .
Neilands, Science, 1967, 156, 1443-1447. This paper relates to hydroxamic acids occurring in nature. Although hydroxamic acids contain . . .
Dittmar et al., 1974, 17, 753-756. This paper describes a structure-activity analysis in a series of antimycotically active 1-hydroxypyrid-2-ones . . .
Durbin, P. W. et al, "Kinetics of Plutonium Deposition in the Mouse," Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Lab. . . .
Durbin, P.W. et al., "New Sequestering Agents for the Actinides . . . ," Ann. Rpt. 1983-4, Biology and Medicine Division, Lawrence Berkeley Labs. . . .
Raymond, K. N., "Specific Sequestering Agents for Iron and Actinides," in Environmental Inorganic Chemistry (VCH Publishers, Inc. 1985). This . . .
Riley, P. E. et al.; "Specific Sequestering Agents for the Actinides. 9 Synthesis of Metal Complexes of 1-Hydroxy-2-Pyridinone . . . ,". . .
Scarrow, R. C. et al, "Ferric Ion Sequestering Agents . . . ," Inorganic Chemistry 24 (1985), pp. 954 et seq. This document discusses HOPO-CO.sub.2 H, . . .
Scarrow et al, CA 102:124493g. This document discloses the thermodynamics of chelation of Co(III) and Fe(III) tris complexes of several chelating . . .
Raymond et al., CA 103:192911n. This document is concerned with the mechanism and specificity of iron transport in Rhodotorula pilimanae probed by . . .
CA 93:130476r. This document is an abstract of Itoh et al., item 1 above in this section.
CA 64:3504d. This document discloses 4-pyridone derivatives useful as sedatives of analgesics.
Bull. Soc. Chim. (1979), No. 11-12, pp. I-451 to I-456 and J. Chem. Res. (1978) (M), pp. 4875-4886 and (S), pp. 404-405 disclose the studies on zinc . . .
J. Am. Chem. Soc. (1957), vol. 79, pp. 1296-1297. This publication describes stability studies on complexes including zinc-maltol, but does . . .
Aust. J. Chem. (1979) vol. 32, pp. 21-30. This document describes stability studies on metal complexes including zinc complexes of certain 3-. . .
Evans "Biological Aspects of Metals . . ." (1983) pp. 81-88. This document describes as an in vitro relationship between zinc and picolinic acid . . .
Bull. Chem. Soc. Japan (1976) vol. 49, pp. 2461-2464, Bull. Soc. Chim. France (1967), No. 8, pp. 2920-2923, Rec. Trav. Chim. Pays-Bas Belg. (1972) . . .
CA 68:8872k.
CA 77:101817s.
Solomons "Nutritional . . . of Zinc" Symposium Series Am. Chem. Soc., 1983, vol. 210, pp. 247-271.
CA 89:35629b, Am. J. Dis. Child (1983) vol. 137, pp. 433-437.
Aggett et al. "Zinc Deficiency in Human Subjects" (1983) pp. 117-124.
Prasad "Biological Aspects of Metal . . . "(1983) pp. 107-119 and "The Economist" (1984) (Mar. 24) pp. 82-83.
J. Chem. Research, (S) (1978), pp. 404-405. This document discusses the thermodynamic stability of maltol and kojic acid complexes with divalent . . .
Recueil (1972) 91, pp. 681-687. This document discloses the ligand properties of hydroxypyrides. The following metal ions are discloses . . .
Bull. Chem. Soc. Japan (1976), vol. 49, pp. 2461-2464. This document discloses the synthesis and properties of bis (3-2-methyl-4-pyronato) . . .
Evans, "Biological Aspects of Metals and Metal Related Diseases", N.Y. (1983), pp. 81-88. This document discusses the relation between . . .
Aust. J. Chem. (1979), vol. 32, pp. 21-30. This paper discloses metal complexes formed by mimosine and related compounds. The following metal . . .
J. Chem. Research (M) (1978), pp. 4873-4881. This document discloses Mn, Co, Ni and Zn complexes with kojic acid and maltol.
CA 69:35956t.
Ca 69:35967x.
CA 69:35968y.
CA 72:12596y.
CA 72:132534y.
CA 72:132537b.
Ann. Rep. Shionogi Research Lab. (1966), vol. 16, pp. 29-40. This document discloses a range of substituted 2-hydroxypyridine 1-oxide compounds, . . .
J. Am. Chem. Soc. (1949), vol. 71, pp. 67-73. This document discloses a range of substituted 1-hydroxypyrid-2-one compounds, including . . .
In. Chim. Acta. (1981), vol. 51, pp. 109-115. This document reports the preparation of various metal complexes of the unsubstituted 1-hydroxypyrid . . .
In. Neucl. Chem. Lett. (1979), vol. 15, pp. 255-258. The cobalt(II) and cobalt (III) complexes of 1-hydroxypyrid-2-one were prepared and studied . . .
Pitt et al., "Development of Iron Chelators for Clinical Use" (1975), p. 137. This paper provides a discussion of alternative types of chelating . . .
J. Chem. Soc., Chem. Comm. (1982) pp. 779-781. This document discusses the preparation of crystalline iron (III) catediolamides.
J. Inorg. Biochem. (1982) vol. 16, pp. 21-32. This document discloses the crystalline molecular structure of piperidinium . . .
Symposium Proceedings, Bethesda, MD (1975) pp. 137-173. This paper does not refer specifically to hydroxypyridones but it does provide a discussion . . .
Aust. J. Biol. Sci., 1976, pp. 189-196. This paper relates to studies on certain metal-free hydroxypyridones as inhibitors of wool folicle DNA . . .
Croatica Chemica Acta CCACAA, 1973, pp. 603-610. This paper is concerned with the use of hydroxypyridone N-substituted by an aromatic group . . .
J. Chem. Soc., Dalton Trans., (1982) pp. 1433-1438. This paper discusses model compounds for microbial iron-transport. It discusses . . .
Ann. Chim., (Rome), vol. 66, Nos. 7-8, 1976, pp. 401-415. This paper discusses equilibrium in kinetics of aquairon (III) monocomplexes formation, and . . .
Rec. Trav. Chim., 65:65 (1946). This paper discusses the isolation and characterization of leucaenine.
CA 97:173875. This document is the Chemical Abstracts corresponding to J. Chem. Soc., Dalton Trans., (1982) pp. 1433-1438 discussed under . . .
CA 87:157681s. This document corresponds to Ann. Chim., (Rome) 1976, 66 (7-8) pp. 401-15 discussed under item 5 above.
J. Chem. Soc., 69:1801 (1947). This document discusses the structure of leucaenine.
Helvetica Chimica Acta, vol. XXIX, fasciculus XII (1946), pp. 1669-1675. This document discloses the structure of leucaenols.
Tetrahedron (1970), vol. 26,

Affiliated with

Also associated with

Rating

Iron complexes of hydroxypyridones useful for treating iron over does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Iron complexes of hydroxypyridones useful for treating iron over, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iron complexes of hydroxypyridones useful for treating iron over will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2349423